CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Recruiting now · Phase 1/Phase 2
Conditions studied: Locally Advanced / Metastatic Solid Tumors
In brief
The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) (RP2D) in participants with locally advanced or metastatic solid tumors.
Key facts
- Study ID
- NCT07335497
- Run by
- Crescent Biopharma, Inc.
- People needed
- 290
- Starts
- 2026-02-17
- Expected to finish
- 2029-02-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Study Site — Madrid, Madrid, Spain (enrolling)
- Clinical Study Site — Los Angeles, California, United States (enrolling)
- Clinical Study Site — Denver, Colorado, United States (enrolling)
- Clinical Study Site — Orlando, Florida, United States (enrolling)
- Clinical Study Site — Sarasota, Florida, United States (enrolling)
- Clinical Study Site — Detroit, Michigan, United States (enrolling)
- Clinical Study Site — Grand Rapids, Michigan, United States (enrolling)
- Clinical Study Site — New York, New York, United States (enrolling)
- Clinical Study Site — Columbus, Ohio, United States (enrolling)
- Clinical Study Site — Pittsburgh, Pennsylvania, United States (enrolling)
- Clinical Study Site — Nashville, Tennessee, United States (enrolling)
- Clinical Study Site — Dallas, Texas, United States (enrolling)
- Clinical Study Site — San Antonio, Texas, United States (enrolling)
- Clinical Study Site — West Valley City, Utah, United States (enrolling)
- Clinical Study Site — Birmingham, Alabama, United States (enrolling)
- Clinical Study Site — Dublin, Ireland, Ireland (enrolling)
- Clinical Study Site — Milan, Milano, Italy (enrolling)
- Clinical Study Site — Cluj-Napoca, Cluj, Romania (enrolling)
- Clinical Study Site — Bucharest, Romania (enrolling)
- Clinical Study Site — Seoul, Seoul, South Korea (enrolling)
- Clinical Study Site — Seoul, Seoul, South Korea (enrolling)
- Clinical Study Site — Seoul, Seoul, South Korea (enrolling)
- Clinical Study Site — Seongnam-si, South Korea (enrolling)
- Clinical Study Site — Barcelona, Barcelona, Spain (enrolling)
- Clinical Study Site — Logroño, La Rioja, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.